PC
NVO

PointState Capital’s Novo Nordisk NVO Stock Holding History

PointState Capital’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-100,000
Closed -$4.8M – 158
2021
Q3 		$4.8M Buy
+100,000
New +$4.83M 0.08% 106
2020
Q4 		– Sell
-42,772
Closed -$1.49M – 149
2020
Q3 		$1.49M Sell
42,772
-92,228
-68% -$3.07M 0.04% 92
2020
Q2 		$4.42M Buy
+135,000
New +$4.31M 0.13% 66
2019
Q3 		– Sell
-120,600
Closed -$3.08M – 132
2019
Q2 		$3.08M Sell
120,600
-72,800
-38% -$1.8M 0.06% 75
2019
Q1 		$5.06M Buy
+193,400
New +$4.75M 0.1% 71

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PointState Capital's NVO Position: Q4 2021 in Review

PointState Capital sold out of Novo Nordisk (NVO) in Q4 2021, closing a stake of 100,000 shares — an estimated $4.8M sold.

PointState Capital first reported a position in NVO in Q1 2019 and held it in 5 quarters. The position peaked at $5.06M in Q1 2019. 886 funds tracked by Wall St. Rank hold NVO as of Q4 2021.

  • PointState Capital reported no remaining Novo Nordisk position as of Q4 2021 after selling out during the quarter.
  • PointState Capital sold 100,000 Novo Nordisk shares in Q4 2021, an estimated $4.8M.
  • PointState Capital first reported a position in Novo Nordisk in Q1 2019 and held it in 5 quarters.
  • PointState Capital's Novo Nordisk position peaked at $5.06M in Q1 2019.
  • 886 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2021.

Based on PointState Capital's 13F filing for Q4 2021, filed 11 Feb 2022.